SCHEMBL19110259

SCHEMBL19110259

c1ccc2c(-c3c4ccccc4c(-c4ccc5cc(-c6ccc7c(c6)sc6ccc8c(ccc9c%10ccccc%10sc98)c67)ccc5c4)c4ccccc34)cccc2c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.39
CYP1A1 P04798 4/20 0.32
CYP1B1 Q16678 4/20 0.32
CYP1A2 P05177 2/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
S1PR4 O95977 4/20 0.32
S1PR5 Q9H228 4/20 0.32
PTPN1 P18031 1/20 0.32
PRKDC P78527 1/20 0.31
PIM1 P11309 1/20 0.30
PARP14 Q460N5 1/20 0.30
NQO1 P15559 1/20 0.30
NQO2 P16083 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945098 0.96 ALOX5 (0.40) ALOX5CYP1A1CYP1B1CYP1A2ALDH1A1
SCHEMBL17945298 0.96 ALOX5 (0.40) ALOX5CYP1A1CYP1B1CYP1A2ALDH1A1
SCHEMBL24341406 0.96 ALOX5 (0.41) ALOX5CYP1A1CYP1B1CYP1A2ALDH1A1
SCHEMBL19110255 0.94 S1PR5 (0.34) ALOX5ALDH1A1MAPTHPGDRAB9A
SCHEMBL24342972 0.94 ALOX5 (0.40) ALOX5CYP1A1CYP1B1CYP1A2ALDH1A1
SCHEMBL24341999 0.93 ALOX5 (0.38) ALOX5ALDH1A1MAPTHPGDRAB9A
SCHEMBL19082378 0.91 CYP1A1 (0.37) ALOX5CYP1A1CYP1B1CYP1A2PIM1
SCHEMBL17945665 0.91 ALOX5 (0.43) ALOX5CYP1A1CYP1B1CYP1A2ALDH1A1
SCHEMBL17944586 0.91 ALOX5 (0.43) ALOX5CYP1A1CYP1B1CYP1A2ALDH1A1
SCHEMBL17945733 0.91 S1PR5 (0.35) ALOX5ALDH1A1MAPTHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-15 US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ALOX5 1871/4885CYP1A1 147/4885CYP1B1 225/4885
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ALOX5 1871/4885CYP1A1 147/4885CYP1B1 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.